2 results
Approved WMOCompleted
The objective of this clinical investigation is to evaluate the short-term clinical feasibility of Vega HP and explore its limitations and advantages. As a result of the evaluations, design changes may be implemented and evaluated until the optimal…
Approved WMORecruiting
The primary objective of the study is to determine the efficacy of AP26113, as evidenced by objective response rate, in patients with ALK positive locally advanced or metastatic NSCLC whose disease has progressed on therapy with crizotinib.